IL-17A stimulates cardiac fibroblast proliferation [50], a component of the pathway resulting in cardiac fibrosis, and is of interest in the consideration of GCR-induced cardiovascular disease. This evidence concerns the gene NR3C1 and cardiovascular disorder.